298380.KQ
ABL Bio Inc.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 67,600.00
−2.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 333.26x
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 21.88x
- Price / sales
- 109.44x
- Price / cash flow
- -89.84x
Enterprise value
- Enterprise value
- KRW 3.64T
- EV / sales
- 106.25x
- EV / EBITDA
- -45.12x
- EV / EBIT
- -42.30x
- Market cap
- KRW 3.75T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026